Presently, Mark J. Fitzpatrick is President & Chief Financial Officer of Chiasma, Inc.

Mr. Fitzpatrick previously occupied the position of Chief Financial Officer for RenaMed Biologics, Inc., Chief Financial Officer & Senior Vice President at WorldStreet Corp., Principal at Repligen Corp., Chief Financial Officer & Vice President for Diacrin, Inc. (Delaware), Chief Financial Officer for Dynogen Pharmaceuticals, Inc., Chief Financial Officer & Vice President for Proteon Therapeutics, Inc., Chief Financial Officer of Aegerion Pharmaceuticals, Inc. and Senior Auditor at Arthur Andersen LLP.

Mr. Fitzpatrick received an undergraduate degree from Boston College.